Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02680145 · ClinicalTrials.gov registry record · NA
Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use
A NA study of Pelvic Organ Prolapse and Uterine Prolapse, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT02680145: Completed NA study of Pelvic Organ Prolapse and Uterine Prolapse, sponsored by Mayo Clinic.
NCT02680145 is a NA study of Pelvic Organ Prolapse and Uterine Prolapse that has completed, run by Mayo Clinic. The registered enrollment target is 58 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02680145, a NA study of Pelvic Organ Prolapse and Uterine Prolapse, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, prospective trial of pessary use prior to reconstructive pelvic floor surgery for pelvic organ prolapse. The goal of the study is to evaluate the change in pelvic floor symptoms with pessary use and subsequent reconstructive surgery. Additionally, we will assess the impact that preoperative pessary use has on patient self-reported preparedness for surgery.
Primary Outcome
Number of participants considered treatment success assessed using the 7-point Likert scale of the Patient Global Impression of Improvement (PGI-I) of 1= very much better and 7=very much worse. Patient's will be considered treatment success if they answer "much better" or "very much better" on the PGI-I scale.
Conditions Studied
Interventions
- DEVICE Preoperative Pessary Use
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-03-11 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT02680145 record still lists
NCT02680145 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (60% lower).
The record links to 4 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Preoperative Pessary Use is the first listed.
NCT02680145 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02680145 about?
NCT02680145 is a clinical study titled "Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use". This is a single center, prospective trial of pessary use prior to reconstructive pelvic floor surgery for pelvic organ prolapse. The goal of the study is to evaluate the change in pelvic floor symptoms with pessary use and subsequent reconstructive surgery. Additionally, we will assess the impact t...
What is the current status of trial NCT02680145?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2016-03-11. Estimated completion is 2019-12-31.
What conditions does trial NCT02680145 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, Uterine Prolapse, Vaginal Vault Prolapse, Pelvic Floor Prolapse.
What interventions are being tested in trial NCT02680145?
The interventions under investigation include: Preoperative Pessary Use (DEVICE).
Who is sponsoring clinical trial NCT02680145?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02680145 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02680145's enrollment target sits among peer trials
58 35th of 40 higher than 6 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
-
The AccelERate Trial
RECRUITING · NA
-
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI